Title : Tofacitinib: A Review in Rheumatoid Arthritis.

Pub. Date : 2017 Dec

PMID : 29139090






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tofacitinib (Xeljanz ) is a potent, selective JAK inhibitor that preferentially inhibits Janus kinase (JAK) 1 and JAK3. tofacitinib Janus kinase 3 Homo sapiens
2 Tofacitinib (Xeljanz ) is a potent, selective JAK inhibitor that preferentially inhibits Janus kinase (JAK) 1 and JAK3. tofacitinib Janus kinase 3 Homo sapiens